Latest liver cancer Stories
-- Plans to Initiate Clinical Studies of Proprietary CAR-T Cell Immunotherapy for Selected Solid Tumors -- SHANGHAI, Nov.
PETACH TIKVA, Israel, Nov. 18, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.
Presented: Monday, November 10, 2014 - Hynes Convention Center, Boston, MA BOSTON, Nov.
LAWRENCEVILLE, N.J., Nov.
SAN ANTONIO, Texas, October 16, 2014 /PRNewswire/ -- GenSpera, Inc.
SAN ANTONIO, Texas, October 9, 2014 /PRNewswire/ -- GenSpera, Inc.
PETACH TIKVA, Israel, Oct. 7, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd.
CF102 has shown to induce healthy liver cell proliferation resulting in improved liver status PETACH TIKVA, Israel, Sept.
- In vivo data support potential clinical benefit of first therapeutic to target a defined subset of liver cancer patients based on genetic profile - CAMBRIDGE, Mass., Sept.
Highly Attended Celsion-Sponsored Symposium on Current Concepts for Treating Intermediate HCC included: New Paradigm in Staging HCC Patients; Phase III Studies in HCC; and Advances in Image Guided